دورية أكاديمية

Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

التفاصيل البيبلوغرافية
العنوان: Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease
المؤلفون: Hernández-Romero, Diana, Sánchez-Quiñones, Jessica, Vílchez, Juan Antonio, Rivera-Caravaca, José Miguel, de la Morena, Gonzalo, Lip, Gregory Y H, Climent, Vicente, Marín, Francisco
المصدر: Hernández-Romero , D , Sánchez-Quiñones , J , Vílchez , J A , Rivera-Caravaca , J M , de la Morena , G , Lip , G Y H , Climent , V & Marín , F 2019 , ' Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease ' , Scientific Reports , vol. 9 , no. 1 , 6235 . https://doi.org/10.1038/s41598-019-42727-4Test
سنة النشر: 2019
المجموعة: Aalborg University (AAU): Publications / Aalborg Universitet: Publikationer
الوصف: Current therapies have not shown benefit in organ damage reversal in Fabry disease (FD), but biomarkers could help risk stratification and prognosis. We investigated if several biomarkers of cardiac fibrosis, cardiac wall stress, myocardial injury, renal function and inflammation, are associated with early cardiac affectation in FD patients. We included FD patients from four cardiology outpatient clinics of southeastern Spain. At inclusion, Galectin-3 (Gal-3), N-terminal proB-type natriuretic peptide, high sensitivity troponin T (hsTnT), β-trace protein (BTP) and interleukin-6 concentrations were measured. The relation of biomarkers concentrations with clinical features, cardiac involvement and organ affectation according to the Mainz Severity Score Index (MSSI) was investigated. 44 FD patients (n = 21 affected and n = 23 unaffected) were compared to age and sex-respectively matched healthy controls. Significant differences in biomarkers' concentration between FD groups were observed. Importantly, Gal-3 and BTP levels were higher in unaffected patients when compared with age and sex-matched healthy controls (both p < 0.05). All the biomarkers correlated with clinical features. When cut-off values for clinical affectation (measured as MSSI ≥ 20) were established, only hsTnT (OR 30.69, 95% CI 2.70-348.42) and male sex (OR 8.17, 95% CI 1.16-57.75) were independently associated with cardiac damage by multivariate regression analysis. Gal-3 and BTP levels are increased in unaffected FD patients compared to healthy controls. This suggests that these biomarkers could be useful for the early detection of cardiac affectation in FD patients. On the other hand, hsTnT and male sex are independent risk factors for established clinical cardiac damage in FD.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: https://vbn.aau.dk/da/publications/9b02719c-82d8-42ba-ae36-ad8c064a517aTest
DOI: 10.1038/s41598-019-42727-4
الإتاحة: https://doi.org/10.1038/s41598-019-42727-4Test
https://vbn.aau.dk/da/publications/9b02719c-82d8-42ba-ae36-ad8c064a517aTest
https://vbn.aau.dk/ws/files/302245951/s41598_019_42727_4.pdfTest
http://www.scopus.com/inward/record.url?scp=85064542404&partnerID=8YFLogxKTest
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.64A6E0C1
قاعدة البيانات: BASE